Abstract
Most of the signal transduction pathways are mediated by protein kinases regulating every aspect of cell function. Mutations which deregulate their expression or their function or both result in cancers. Therefore, protein kinase inhibitors have become the focus of development of new therapies for cancer. A comprehensive review of Choline kinase (ChoK) was published by us in 2003. Since then, molecular information of ChoK inhibitors has been accumulated. In this review, we intend to summarize the new lines of evidence that will include the design of the most active antiproliferative agents so far described against ChoK. Studies have been aimed at the establishment of structure-activity relationships and the structural parameters that define ChoK inhibitory and antiproliferative activities of a set of twenty-five acyclic biscationic pyridophane and forty acyclic biscationic quinolinephane compounds. The corresponding QSAR equation was obtained for the whole set of bisquinolinium compounds for the antiproliferative activity, taking into consideration the electronic parameter σR of R4, the molar refractivity (MR) of R8, and the lipophilic parameters clog P and πlinker. The most potent antiproliferative agent shows an IC50 = 0.45 μM, predicted by the QSAR equation, whilst its experimental value is IC50 = 0.20 μM. Finally, toxicity assays were performed for the most promising compounds because of their interesting antiproliferative activities [IC50 HT-29 = 0.70, 0.80, 1.50 and 1.90 μM] and low toxicity [LD50 = 16.7, 12.5, > 25 and > 20 μg/kg of mouse]. These biological activities justify further analysis for antitumoral assays under in vivo conditions.
Keywords: Ab initio calculations, Antitumor drugs, Bispyridinium compounds, Bicyclophanes, Bisquinolinium compounds, Cyclophanes, Choline Kinase, QSAR
Current Medicinal Chemistry
Title: (Q)SAR Studies to Design New Human Choline Kinase Inhibitors as Antiproliferative Drugs
Volume: 13 Issue: 11
Author(s): J. M. Campos, R. M. Sanchez-Martin, A. Conejo-Garcia, A. Entrena, M. A. Gallo and A. Espinosa
Affiliation:
Keywords: Ab initio calculations, Antitumor drugs, Bispyridinium compounds, Bicyclophanes, Bisquinolinium compounds, Cyclophanes, Choline Kinase, QSAR
Abstract: Most of the signal transduction pathways are mediated by protein kinases regulating every aspect of cell function. Mutations which deregulate their expression or their function or both result in cancers. Therefore, protein kinase inhibitors have become the focus of development of new therapies for cancer. A comprehensive review of Choline kinase (ChoK) was published by us in 2003. Since then, molecular information of ChoK inhibitors has been accumulated. In this review, we intend to summarize the new lines of evidence that will include the design of the most active antiproliferative agents so far described against ChoK. Studies have been aimed at the establishment of structure-activity relationships and the structural parameters that define ChoK inhibitory and antiproliferative activities of a set of twenty-five acyclic biscationic pyridophane and forty acyclic biscationic quinolinephane compounds. The corresponding QSAR equation was obtained for the whole set of bisquinolinium compounds for the antiproliferative activity, taking into consideration the electronic parameter σR of R4, the molar refractivity (MR) of R8, and the lipophilic parameters clog P and πlinker. The most potent antiproliferative agent shows an IC50 = 0.45 μM, predicted by the QSAR equation, whilst its experimental value is IC50 = 0.20 μM. Finally, toxicity assays were performed for the most promising compounds because of their interesting antiproliferative activities [IC50 HT-29 = 0.70, 0.80, 1.50 and 1.90 μM] and low toxicity [LD50 = 16.7, 12.5, > 25 and > 20 μg/kg of mouse]. These biological activities justify further analysis for antitumoral assays under in vivo conditions.
Export Options
About this article
Cite this article as:
Campos M. J., Sanchez-Martin M. R., Conejo-Garcia A., Entrena A., Gallo A. M. and Espinosa A., (Q)SAR Studies to Design New Human Choline Kinase Inhibitors as Antiproliferative Drugs, Current Medicinal Chemistry 2006; 13 (11) . https://dx.doi.org/10.2174/092986706776872961
DOI https://dx.doi.org/10.2174/092986706776872961 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances in the Chemistry of Quinoxalinone Derivatives
Mini-Reviews in Organic Chemistry P1 and P1; Optimization of [3,4]-Bicycloproline P2 Incorporated Tetrapeptidyl α-Ketoamide Based HCV Protease Inhibitors
Letters in Drug Design & Discovery Protein Kinase CK2 in Human Diseases
Current Medicinal Chemistry Pericyclic Reactions for Antivirals: Synthesis of 4-Bromo-N-[(1R*,4S*)-4- hydroxy-2-cyclohexen-1-yl]-2-thiazolecarboxamide
Letters in Organic Chemistry Sulfated Oligosaccharides: New Targets for Drug Development?
Current Medicinal Chemistry Editorial from Guest Editor [Hot topic: The Optimal Care of the Lung in the Critically Ill (Guest Editor: Ross Freebairn)]
Current Respiratory Medicine Reviews Preface
Current Proteomics Proteomic Analysis of Neutrophil Priming by PAF
Protein & Peptide Letters Nitric Oxide and its Role During Pregnancy: From Ovulation to Delivery
Current Pharmaceutical Design Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents
Current Pharmaceutical Design The Role of Image Guided Radiotherapy in the Treatment of Soft Tissue Sarcoma
Current Cancer Therapy Reviews The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms
Current Pharmaceutical Design One-pot Synthesis of Pyrano[2,3-c]pyrazole Derivatives <i>via</i> Multicomponent Reactions (MCRs) and their Applications in Medicinal Chemistry
Mini-Reviews in Organic Chemistry Design, Synthesis and Antitumor Activity of Novel Cis-Furoquinoline Derivatives
Letters in Drug Design & Discovery Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry 1,2,4-Oxadiazoles Identified by Virtual Screening and their Non-Covalent Inhibition of the Human 20S Proteasome
Current Medicinal Chemistry Synthesis and Characterization of Quinoline-3-Carboxamide Derivatives as Inhibitors of the ATM Kinase
Current Topics in Medicinal Chemistry Design of N-substituted Amino Caproic Hydroxamic Acid Histone Deacetylase Inhibitors Reveal an Essential Role for Cap Atomic Composition
Anti-Cancer Agents in Medicinal Chemistry Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Direct Covalent Modification as a Strategy to Inhibit Nuclear Factor-Kappa B
Current Medicinal Chemistry